Literature DB >> 6298040

Nerve function and metabolic control in teenage diabetics.

R J Young, D J Ewing, B F Clarke.   

Abstract

Peripheral somatic and autonomic nerve function have been studied in 79 teenage (16-19 yr) diabetics and 20 age- and sex-matched normal controls. Almost three-quarters of the diabetics (72%) had abnormal peripheral somatic nerve function tests, and one-third (31%) had abnormal cardiac parasympathetic tests. Both motor and sensory peripheral somatic nerve abnormalities were related to poor prevailing glycemic control (HbA1) and duration of diabetes. Thus, the 27 patients with three or more (maximum six) peripheral nerve abnormalities had significantly higher HbA1 levels (P less than 0.001) and longer duration of diabetes (P less than 0.01) than the 22 with no abnormalities. Individual peripheral somatic nerve tests almost invariably correlated only with HbA1 (median motor, P less than 0.05; peroneal motor, P less than 0.001; sural sensory, P less than 0.001) or duration of diabetes (median sensory, P less than 0.001). Sensory potential amplitude, as well as conduction velocity, was frequently reduced, implying axonal involvement. These findings suggest that abnormal peripheral and autonomic nerve function are common in young insulin-dependent diabetics and that poor metabolic control is a major determinant of the damage. DIABETES 32:142-147, February 1983.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298040     DOI: 10.2337/diab.32.2.142

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  29 in total

1.  Hyperglycaemia stimulates pyloric motility in normal subjects.

Authors:  R Fraser; M Horowitz; J Dent
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

2.  Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy.

Authors:  L Wuarin-Bierman; G R Zahnd; F Kaufmann; L Burcklen; J Adler
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

3.  Impact of glycemic control on heart rate variability in youth with type 1 diabetes: the SEARCH CVD study.

Authors:  Mamta Jaiswal; Tasha E Fingerlin; Elaine M Urbina; R Paul Wadwa; Jennifer W Talton; Ralph B D'Agostino; Richard F Hamman; Stephen R Daniels; Santica M Marcovina; Larry M Dolan; Dana Dabelea
Journal:  Diabetes Technol Ther       Date:  2013-09-06       Impact factor: 6.118

Review 4.  Can retinopathy be prevented?

Authors:  B Weber; G Hövener; W Burger; R Hartmann; I Enders
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

5.  Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients.

Authors:  D L Eckberg; S W Harkins; J M Fritsch; G E Musgrave; D F Gardner
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

6.  Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy.

Authors:  F J Service; R A Rizza; J R Daube; P C O'Brien; P J Dyck
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122

7.  Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients.

Authors:  D Ziegler; K Wiefels; K Dannehl; F A Gries
Journal:  Klin Wochenschr       Date:  1988-05-02

8.  The natural course of peripheral and autonomic neural function during the first two years after diagnosis of type 1 diabetes.

Authors:  D Ziegler; I Cicmir; P Mayer; K Wiefels; F A Gries
Journal:  Klin Wochenschr       Date:  1988-11-01

9.  Autonomic neuropathy and survival in diabetes mellitus: effects of pancreas transplantation.

Authors:  X Navarro; W R Kennedy; D E Sutherland
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

10.  Peroneal motor nerve conduction velocity in diabetic children and adolescents. Relationships to metabolic control, HLA-DR antigens, retinopathy, and EEG.

Authors:  H Dorchy; P Noel; M Kruger; V de Maertelaer; E Dupont; D Toussaint; S Pelc
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.